Clinical Trials
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
AC Immune & Lilly Partner for Alzheimer's
The license and collaboration agreement is to research and develop tau aggregation inhibitor small molecules for the potential treatment of AD12.12.18
-
Breaking News | Clinical Trials | CRO News | Drug Development
Rho Adds Regulatory Strategy and Submissions Biz
Will support sponsors in planning, developing and submitting marketing applications12.11.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
CBT & Strata Oncology Enter Development Deal
To drive patient enrollment in CBT’s ongoing Phase 1/2 trial of CBT-101 in patients with c-Met dysregulated malignancies including non-small cell lung cancer12.10.18
-
Breaking News | Clinical Trials | Drug Development | Industry News
Eisai, UCL Alliance Advances Alzheimer's Candidate
Phase I trial of E2814, an anti-tau monoclonal antibody, will assess the ability to slow the progression of AD12.07.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Biogen Licenses ALS Treatment from Ionis
Obtained worldwide, exclusive, royalty-bearing license to develop and commercialize BIIB067 (IONIS-SOD1RX)12.06.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D
VBI, Brii Bio Partner for Hepatitis B
Brii Bio paid VBI $11 million upfront, including a $4 million upfront payment & a $7 million equity investment at $3 a share12.06.18
-
Breaking News | Clinical Trials | CRO News
PAREXEL, Lilly to Develop China’s Clinical Research Workforce
Program aims to bring high-value training opportunities to China’s clinical trial sites12.06.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
iDD Biotech Receives Second Milestone
Milstone was initiated after its partner, Genmab, started a Phase I/IIa trial of GEN102912.04.18
-
Breaking News | Clinical Trials | CRO News | Industry News
QPS Expands U.S.-Based Phase I Clinical Trial Services
Supports growing needs of its pharmaceutical, biotech and CRO partners12.03.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
TRACON & I-Mab Partner for Immuno-Oncology
TRACON to be responsible for the regulatory & clinical development of I-Mab's TJD5 & up to five of the BsAbs in North America11.29.18
-
Clinical Trials | Drug Development | GMPs/GCPs | Information Technology
Update on ICH E6 R2 Guideline for GCP
Patrick Hughes of CluePoints discusses opportunities and advantages of the new guidance and considers possible limitationsPatrick Hughes, Chief Commercial Officer, CluePoints 11.27.18
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development
Aileron, Pfizer in Clinical Collaboration
To evaluate the combination of Aileron’s ALRN-6924 and Pfizer’s IBRANCE in cancer11.27.18
-
Clinical Trials
Myoderm
Myoderm is a leader in the sourcing, distribution, and management of commercial pharmaceutical products and supplies for clinical trials. Our clients span the globe and include biotech companies, CROs, clinical trial packagers, and a majority of the…Maryanne L. Walsh, Director, Marketing and Sales Operations 11.26.18
-
Breaking News | Clinical Trials | CRO News | Industry News
Adial Pharma Selects Crown CRO for Phase III Trial
AD04 trial in alcohol use disorder will enroll 290 patients in 30 clinical sites across Europe11.19.18
-
Breaking News | Clinical Trials | Collaborations & Alliances | CRO News | Information Technology
SHYFT Analytics, PAREXEL Enter Strategic RWE Pact
Will leverage SHYFT’s technology for Real-World Evidence generation and outcomes research11.12.18
-
Breaking News | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
Ziopharm, Regeneron In Clinical Supply Pact
Will evaluate Ziopharm’s Ad-RTS-hIL-12 plus veledimex with Regeneron’s PD-1 antibody Libtayo in recurrent glioblastoma11.12.18
-
Clinical Trials | Facilities | Logistics
Cryoport Tackles Market Needs with New NJ Facility
Contract Pharma spoke with Cryoport’s CEO, Jerry Shelton, on the reasons behind the new Global Logistics Center's launchOnline Exclusives11.02.18
-
Bio News | Clinical Trials | Industry News | R&D | Trials & Filings
Janssen Receives FDA Approval for INVOKANA
To reduce risk of major adverse cardiovascular events, in adults with type 2 diabetes (T2D) who have established CV disease10.30.18
-
Breaking News | Clinical Trials | CRO News
Rho Joins Avoca Quality Consortium
Gains access to AQC Knowledge Center with leading practices, guidelines, tools, and templates aimed at improving quality10.30.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Kazia, Dana-Farber Cancer Institute Partner for Cancer
To investigate use of Kazia’s potential new therapy for brain cancer, GDC-0084, in breast cancer that has spread to the brain10.22.18
